medigraphic.com
ISSN 1405-1710 (Print)

2022, Number 1-2

<< Back Next >>

Rev Cent Dermatol Pascua 2022; 31 (1-2)

Tumors with sebaceous differentiation. Presentation of three cases and review of the literature

Ortiz-Lobato L, Navarrete-Franco G, González-González M, Domínguez-Malagón HR, Parra-Jaramillo LS, Santos-Ortíz MF

Language: Spanish
References: 30
Page: 34-42
PDF size: 556.77 Kb.


ABSTRACT

Sebaceous tumors are a rare type of adnexal tumors that usually appear in older adults. Its most frecuently topography compromises head and neck. Currently, it´s classified in three groups: sebaceous adenoma, sebaceoma, and sebaceous carcinoma. In this article, we report the cases of three patients with sebaceous lineage tumors that presented at different ages of life.


REFERENCES

  1. Brownell I, Lemis CA, Koss T. Dermatología. 4ta edición. España: Elsevier. pp. 56-65.

  2. Iacobelli J, Harvey N, Wood B. Sebaceous lesions of the skin. Pathology. 2017; 49: 688-697. doi: 10.1016/j.pathol.2017.08.012.

  3. Tirado M, Metze D, Sahlmann J, Boer-Auer A. Cytologic grading of cutaneous sebaceous neoplasms: does it help to differentiate benign from malignant? Am J Dermatopathol. 2019; 41: 722-732. doi: 10.1097/DAD.0000000000001434.

  4. Kim JE, Kim JH, Chung KY, Yoon JS, Roh MR. Clinical features and association with visceral malignancy in 80 patients with sebaceous neoplasms. Ann Dermatol. 2019; 31: 14-21. doi: 10.5021/ad.2019.31.1.14.

  5. Flux K. Sebaceous neoplasms. Surg Pathol Clin. 2017; 10: 367-382. doi: 10.1016/j.path.2017.01.009.

  6. Machado-Chavelas A, Ramos-Garibay A. Adenoma sebáceo. Rev Cent Dermatol Pascua. 2008; 17: 19-21. Disponible en: https://www.medigraphic.com/pdfs/derma/cd-2008/cd081e.pdf

  7. Darias C, Piña Y, Lima M. Neoplasias de origen sebáceo asociadas a síndrome de Muir-Torre. A propósito de un caso. Rev Med Electrónico. 2017; 39: 584-591. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242017000300017&lng=es

  8. Calonje E, Brenn T, Lazar A, Billings S. McKee's pathology of the skin with clinical correlations. 5th edition. Elsevier. 2020, pp. 1596-1598.

  9. Reinhart J, James W. Sebaceous adenoma in the setting of immunosuppression for kidney transplantation. JAAD Case Reports. 2019; 5: 818-820. doi: 10.1016/j.jdcr.2019.07.027.

  10. Monti FC, Bonetto VN, Valente E, Kurpis M, Ruiz LA. Sebaceoma-epitelioma sebáceo. Arch Argent Dermatol. 2010; 60: 233-237. Disponible en: https://docplayer.es/23865886-Sebaceoma-epitelioma-sebaceo.html

  11. Calonje J, Brenn T, Lazar A. Tumors and related lesion of the sebaceous glands. McKee's Pathology of the Skin. 5th Ed. United States of America: Elsevier; 2020. pp. 1589-1610.

  12. Ferreira I, Wiedemeyer K, Demetter P, Adams DJ, Arends MJ et al. Update on the pathology, genetics and somatic landscape of sebaceous tumours. Histopathology. 2019; 76: 640-649. doi: 10.1111/his.14044.

  13. Lee DW, Kwak SH, Kim JH, Byeon JY, Lee HJ, Choi HJ. Sebaceous carcinoma arising from sebaceoma. Arch Craniofac Surg. 2021; 22: 126-130. doi: 10.7181/acfs.2021.00059.

  14. Bourlond F, Cribier B, Lipsker D, Velter C. Tumeurs sébacées et syndrome de Muir-Torre [Sebaceous tumors and Muir-Torre syndrome]. Ann Dermatol Venereol. 2015; 142: 456-459. doi: 10.1016/j.annder.2015.03.012.

  15. Coppola R, Carbotti M, Zanframundo S, Verona RM, Graziano A, Panasiti V. Use of dermoscopy in the diagnosis of sebaceoma. J Am Acad Dermatol. 2015; 72: e143-e145.

  16. Nomura M, Tanaka M, Nunomura M, Izumi M, Oryu F. Dermoscopy of rippled pattern sebaceoma. Dermatol Res Pract. 2010; 2010: 140486. doi: 10.1155/2010/140486.

  17. Gay J, Gross G. Muir-Torre syndrome. Treasure Island (FL). Stat Pearls. 2021.

  18. Al-Khashnam H, Burezq H, Al-Aradi I, Al-Sabah H, Al-Abdulhadi K. Unusual malignant transformation of recurrent sebaceoma. A case report. Clin Med Oncol. 2008; 2: 389-392. doi: 10.4137/cmo.s477.

  19. Ribero S, Baduel ES, Brizio M, Picciotto F, Dika E, Fierro MT et al. Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality. Radiol Oncol. 2016; 50: 308-312. doi: 10.1515/raon-2016-0039.

  20. Eyssautier SF, Cabezas CL, Álvarez TM, Papuzinski AC, Sáez CE. Carcinoma sebáceo extraocular, reporte de un caso. Rev Otorrinolaringol Cir Cabeza Cuello. 2019; 79: 98-104. doi: 10.4067/S0718-48162019000100098.

  21. González-Almaraz G, Aineda-Cárdenas M. Carcinoma sebáceo. Rev Cent Dermatol Pascua. 1999; 8: 76-85. Disponible en: https://dcmq.com.mx/edición-octubre-diciembre-2013-volumen-11-número-4/198-carcinoma-sebáceo-informe-de-un-caso

  22. Kyllo R, Brady K, Hurst E. Sebaceous carcinoma: review of the literature. Dermatologic Surg. 2015; 41: 1-15. doi: 10.1097/DSS.0000000000000152.

  23. Moliné J, Ferrari B, Alperovich R, Waimann J, Acosta AC, Schroh R et al. Carcinoma sebáceo. Sebaceous carcinoma. Dermatol Argent. 2013; 19: 112-116. Disponible en: https://www.dermatolarg.org.ar/index.php/dermatolarg/article/download/1064/615

  24. Knackstedt T, Samie F. Sebaceous carcinoma: a review of the scientific literature. Curr Treat Options Oncol. 2017; 18: doi: 10.1007/s11864-017-0490-0.

  25. Imko-Walczuk B, Kry?c A, Lizakowski S, Debska-?lizie?d A, Rutkowskid B, Biernate W et al. Sebaceous carcinoma in patients receiving long-term immunosuppressive treatment: case report and literature review. Transplant Proc. 2014; 46: 2903-2907. doi: 10.1016/j.transproceed.2014.09.064.

  26. Bolm I, Babaryka G, Moergel M, Al-Nawas B, Kammerer PW. Multifocal metastasizing extra-ocular facial sebaceous carcinoma as diagnostic challenge: case report and systematic review. J Maxillofac Oral Surg. 2015; 14: 331-337. doi: 10.1007/s12663-013-0547-y.

  27. Jung YH, Woo IS, Kim MY, Han CW, Rha EY. Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: case report and literature review. Asia Pac J Clin Oncol. 2016; 12: e189-e193. doi: 10.1111/ajco.12088.

  28. Kumar V, Xu Y. Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: Is genotyping a right answer for guiding chemotherapy in rare tumours? Curr Oncol. 2015; 22: e316-e319. doi: 10.3747/co.22.2467.

  29. Vaglio GG, Leiva MJ, Ferrario D, Volonteri V, Kowalczuk A, Vaccaro C et al. Tumores sebáceos: ¿Tan inocentes como creemos? Síndrome de Muir-Torre. Dermatología CMQ. 2014; 12: 24-28. Disponible en: https://dcmq.com.mx/edición-enero-marzo-2014-volumen-12-número-1/222-tumores-sebáceos-¿tan-inocentes-como-creemoss%C3%ADndrome-de-muir-torre

  30. John AM, Schwartz RA. Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016; 74: 558-566. doi: 10.1016/j.jaad.2015.09.074




2020     |     www.medigraphic.com